CLBS03 / Lisata Therapeutics - LARVOL DELTA

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study) (clinicaltrials.gov) - P2; N=113; Completed; Sponsor: Caladrius Biosciences, Inc.; Active, not recruiting ➔ Completed

Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus